Photo of Kate Hardey

Kate advises healthcare provider, pharmaceutical, medical device, dietary supplement and life sciences clients on regulatory and compliance matters and in all types of transactions including sales and acquisitions, as well as advising lenders and investors evaluating regulatory risks in cash flow and asset based debt financing transactions.

It’s deal time! The 2016 JP Morgan Healthcare Conference has set the tone for another successful year for healthcare investing. A company’s financial health is a key factor in the underwriting process for any type of loan and, in the
Continue Reading Healthcare Regulatory Diligence: “What Does it Mean to Financial Underwriting?”